QB
Q BioMed Inc.
QBIO · OTC
$0.00 +0.00% (+$0.00)
Market Cap $14.5K
P/E Ratio -
Div. Yield -
ROE -
Analiza
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/FCF 0.01x
P/S 0.05x
EV/EBITDA N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
30 /100
Weak Net margin 721.67%
Op. margin 1,211.74%
FCF margin 682.75%
Quality
59 /100
Average ROA 58.37%
Asset turnover 0.08x
ROIC 679.02%
Debt
50 /100
Moderate Int. coverage -0.48x
Net debt/EBITDA -6.57x
Current ratio 0.01x
Stability
47 /100
Moderate EPS volatility 29.87%
Profitable years 0
Beta -154.93x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o QBIO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Denis D. Corin
Employees
3
Headquarters
New York City